Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: An Update
Benefits of Medications ( 2 of 2 )
Regarding the use of calcium in combination with the bisphosphonates, one head-to-head trial found that adding calcium to alendronate treatment reduced the risk of any type of clinical fracture when compared with alendronate alone. Strength of Evidence = Low
Keywords: bone | low bone density | bone density | osteoporosis | fracture | osteopenia | skeletal | postmenopausal | vertebral | nonvertebral | hip | wrist | clinical fracture | alendronate | calcium | bisphosphonate | risk
- Newberry SJ, Crandall CC, Gellad WG, et al. Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis: An Update to the 2007 Report. Comparative Effectiveness Review No. 53 (Prepared by the Southern California Evidence-based Practice Center under Contract No. HHSA 290-2007-10062-I). Rockville, MD: Agency for Healthcare Research and Quality; February 2012. AHRQ Publication No. 12-EHC023-EF. Available at www.effectivehealthcare.ahrq.gov/reports/lbd.cfm.
Your slide tray is being processed.